Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus
- PMID: 18359309
- DOI: 10.1016/j.amjcard.2007.11.037
Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus
Abstract
Renal dysfunction is an independent risk factor for cardiovascular (cv) disease and its associated complications. Diabetes mellitus (dm) is a common cause of renal dysfunction. Whether the presence or absence of dm modifies the relation between renal dysfunction and cv disease is unclear. The valiant trial identified 14,527 patients with acute myocardial infarction complicated by either clinical or radiologic signs of heart failure and/or left ventricular dysfunction for whom baseline creatinine was measured. Patients were randomly assigned to receive captopril, valsartan, or both. Glomerular filtration rate (gfr) was estimated using the 4-component modification of diet in renal disease equation. Using multivariable cox proportional modeling, the relation of overall mortality and composite cardiovascular events with estimated gfr (egfr) between patients with and without dm was compared. Mean egfrs were 66.8 +/- 22.0 and 71.2 +/- 21.0 ml/min/1.73 m2 for patients with (n = 3,358) and without dm (n = 11,169), respectively. The likelihood of experiencing death or the composite end point was higher in patients with than without dm for each level of renal function. the augmentation in risk of cv events based on reduced renal function was similar between groups. Each decrease in egfr by 10 units was associated with hazards of 1.09 (95% confidence interval 1.06 to 1.12, p <0.001) in patients with dm and 1.08 (95% confidence interval 1.06 to 1.10, p <0.001) in patients without dm for risk of fatal and nonfatal cv outcomes independent of treatment assignment. In conclusion, although dm is associated with higher risk of renal dysfunction and adverse cv outcomes, patients without dm had a relation between renal function and cv risk similar to that for patients with dm after high-risk acute myocardial infarction.
Similar articles
-
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.N Engl J Med. 2004 Sep 23;351(13):1285-95. doi: 10.1056/NEJMoa041365. N Engl J Med. 2004. PMID: 15385655 Clinical Trial.
-
Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).Am J Cardiol. 2009 Jul 15;104(2):151-7. doi: 10.1016/j.amjcard.2009.03.020. Epub 2009 Jun 3. Am J Cardiol. 2009. PMID: 19576338 Clinical Trial.
-
Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).Circulation. 2005 Nov 29;112(22):3391-9. doi: 10.1161/CIRCULATIONAHA.105.551143. Epub 2005 Nov 21. Circulation. 2005. PMID: 16301343 Clinical Trial.
-
Impaired renal function in acute myocardial infarction.Cardiol J. 2009;16(5):400-6. Cardiol J. 2009. PMID: 19753517 Review.
-
Renal dysfunction and coronary disease: a high-risk combination.J Nephrol. 2009 Jan-Feb;22(1):39-45. J Nephrol. 2009. PMID: 19229817 Review.
Cited by
-
The role of clopidogrel resistance-related genetic and epigenetic factors in major adverse cardiovascular events among patients with acute coronary syndrome after percutaneous coronary intervention.Front Cardiovasc Med. 2023 Feb 8;9:1027892. doi: 10.3389/fcvm.2022.1027892. eCollection 2022. Front Cardiovasc Med. 2023. PMID: 36843628 Free PMC article.
-
Long-Term Clinical Outcome according to Changes of Glomerular Filtration Rate in AMI Patients with Multivessel Disease after Percutaneous Coronary Intervention.Chonnam Med J. 2020 May;56(2):121-129. doi: 10.4068/cmj.2020.56.2.121. Epub 2020 May 25. Chonnam Med J. 2020. PMID: 32509559 Free PMC article.
-
Pharmacological interventions for heart failure in people with chronic kidney disease.Cochrane Database Syst Rev. 2020 Feb 27;2(2):CD012466. doi: 10.1002/14651858.CD012466.pub2. Cochrane Database Syst Rev. 2020. PMID: 32103487 Free PMC article.
-
Effect of single and dual renin-angiotensin blockade on stroke in patients with and without diabetes in VALIANT.Eur Stroke J. 2016 Jun;1(2):93-100. doi: 10.1177/2396987316646025. Epub 2016 May 9. Eur Stroke J. 2016. PMID: 31008270 Free PMC article.
-
Evaluation of the impact of chronic kidney disease on the survival of octogenarian patients submitted to percutaneous coronary intervention.Indian Heart J. 2018 Nov-Dec;70(6):848-851. doi: 10.1016/j.ihj.2018.06.009. Epub 2018 Jun 30. Indian Heart J. 2018. PMID: 30580855 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
